Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) EPS (Basic): 2023-2025

Historic EPS (Basic) for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -$0.63.

  • Upstream Bio's EPS (Basic) rose 90.95% to -$0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.69, marking a year-over-year increase of 146.10%. This contributed to the annual value of -$5.58 for FY2024, which is 56.91% up from last year.
  • Latest data reveals that Upstream Bio reported EPS (Basic) of -$0.63 as of Q3 2025, which was up 14.86% from -$0.74 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's EPS (Basic) registered a high of $12.57 during Q4 2024, and its lowest value of -$6.96 during Q3 2024.
  • Over the past 3 years, Upstream Bio's median EPS (Basic) value was -$2.11 (recorded in 2023), while the average stood at -$1.62.
  • Over the last 5 years, Upstream Bio's EPS (Basic) had its largest YoY gain of 348.91% in 2024, and its largest YoY loss of 229.86% in 2024.
  • Upstream Bio's EPS (Basic) (Quarterly) stood at -$5.05 in 2023, then skyrocketed by 348.91% to $12.57 in 2024, then soared by 90.95% to -$0.63 in 2025.
  • Its EPS (Basic) stands at -$0.63 for Q3 2025, versus -$0.74 for Q2 2025 and -$0.51 for Q1 2025.